Invasive Bladder Carcinoma — Trials

Invasive Bladder Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

179 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 95
Recruiting: 59
Ph III recruiting: 12
Growth YoY: +28.6%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 58.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05176145	Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test(DMIA)	unknown	N/A	400	VitadxOTHER	3	Oct 13, 2023	clinicaltrials
NCT05084586	Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation	unknown	N/A	100	Ankara Training and Research HospitalOTHER	1	Mar 28, 2023	clinicaltrials